HESTERBIO — Hester Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹14.58bn
- IN₹16.56bn
- IN₹3.11bn
- 82
- 13
- 57
- 50
Annual cashflow statement for Hester Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 501 | 535 | 402 | 320 | 396 |
| Depreciation | |||||
| Non-Cash Items | 93.5 | -54.8 | -83.1 | 70.5 | 96.6 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -147 | -558 | -289 | -80.4 | -15.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 581 | 88.1 | 236 | 481 | 645 |
| Capital Expenditures | -407 | -957 | -778 | -244 | -206 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 23.7 | -209 | 7.63 | 17.4 | 15.9 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -384 | -1,166 | -770 | -227 | -190 |
| Financing Cash Flow Items | 83.3 | 36.5 | 114 | 111 | -131 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -182 | 1,116 | 418 | -260 | -517 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -22.6 | 34.8 | -116 | -4.08 | -67.2 |